Discussion Forums > Working Towards a Cure
Gene Therapy Update From The Philadelphia Conference.
Andy Battaglia:
JV you are correct. The time frame for gene therapy issued by CAF is on a ten year plan. JV, I wish you could have been at Philly this weekend. I got to meet Amy C who knows you.
JV:
I know, very upset about missing the conference but had family stuff. Amy C and Anthony Viola said so many great things about the weekend. The North Jersey Chapter, along with New York and Long Island are very active and we hope to see you at some of our future events.
It is truly amazing....we are on the cusp of history...we have the opportunity to wipe out a major disorder (don't call it a disease anymore) in the very near future. This WILL happen....
Andy Battaglia:
I felt honored when Tony Viola thanked me and mentioned my work with thalpal to the audience. It was unexpected but greatly appreciated. For me personally, it was wonderful to see the acceptance given me by the people at CAF. And it paid off imediately, as doctors were quite happy to talk to me at length about the problems of some of our members. It isn't for myself that I want the recognition. It is because it means more access to the people that can help the most.
Sushil:
10 Year is fine to me. My daughter is 4 year old so I am happy that her youth age will be thal free :yahoo :cheer. Touchwood knock knock.
Dharmesh:
--- Quote from: Andy on July 02, 2013, 10:26:05 PM ---I felt honored when Tony Viola thanked me and mentioned my work with thalpal to the audience. It was unexpected but greatly appreciated. For me personally, it was wonderful to see the acceptance given me by the people at CAF. And it paid off imediately, as doctors were quite happy to talk to me at length about the problems of some of our members. It isn't for myself that I want the recognition. It is because it means more access to the people that can help the most.
--- End quote ---
Congratulationsss Dear Andy :biggrin :bighug :congrats
Navigation
[0] Message Index
[#] Next page
[*] Previous page
Go to full version